Stifel Financial is a top pick for long-term growth with solid Q424 results, a 10% dividend hike & solid wealth management ...

Stifel analysts maintained their Buy rating on Iovance Biotherapeutics (NASDAQ:IOVA), currently trading at $5.24, with a steady price target of $21.00. According to InvestingPro data, analyst targets ...

Stifel analyst Paul Matteis lowered the firm’s price target on Biogen (BIIB) to $144 from $175 and keeps a Hold rating on the shares. The ...

Stifel analysts increased the price target for Confluent Inc (NASDAQ:CFLT), a data streaming platform, from $37.00 to $40.00, ...

Proprietary Insights – Stifel Discover delivers exclusive analysis and commentary from Stifel’s Chief Investment Officer, Chief Economist, Chief Washington Policy Strategist, equity research analysts, ...

GATX Corporation (NYSE: GATX) announced the cancellation of its presentation and webcast at the Stifel 2025 Transportation & ...

MoneyLion operates a “content-as-a-service platform” called mFeed, and Stifel Discover is expected to deliver personalized ...

On January 31, Stifel reduced Intel’s price target from $25 to $21 while maintaining a Hold rating. The firm noted that ...

Over the past five years, Stifel has hired 450 advisors, with a cumulative trailing 12-month production of more than $350 million, according to CFO Marischen. That has driven the wealth division’s ...

Tesla (NASDAQ:TSLA – Get Free Report) had its price objective cut by research analysts at Stifel Nicolaus from $492.00 to ...

Stifel Financial Corp. provides securities brokerage, investment banking, trading, investment advisory and related financial services. It operates through the following segments: Global Wealth ...